| Literature DB >> 19574017 |
Christina S Meade1, Scott E Lukas, Leah J McDonald, Garrett M Fitzmaurice, Jessica A Eldridge, Nancy Merrill, Roger D Weiss.
Abstract
This pilot study tested the effectiveness of transcutaneous electric acupoint stimulation (TEAS) as an adjunctive treatment for inpatients receiving opioid detoxification with buprenorphine-naloxone at a private psychiatric hospital. Participants (N = 48) were randomly assigned to active or sham TEAS and received three 30-minute treatments daily for 3 to 4 days. In active TEAS, current was set to maximal tolerable intensity (8-15 mA); in sham TEAS, it was set to 1 mA. By 2 weeks postdischarge, participants in active TEAS were less likely to have used any drugs (35% vs. 77%, p < .05). They also reported greater improvements in pain interference (F = 4.52, p < .05) and physical health (F = 4.84, p < .01) over time. TEAS is an acceptable, inexpensive adjunctive treatment that is feasible to implement on an inpatient unit and may be a beneficial adjunct to pharmacological treatments for opioid detoxification.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19574017 PMCID： PMC2789908 DOI： 10.1016/j.jsat.2009.05.010
Source DB: PubMed Journal: J Subst Abuse Treat ISSN： 0740-5472